Imricor Medical Systems, Inc. (ASX: IMR) Submits NorthStar for CE Mark Approval
Imricor submits NorthStar for CE Mark approval and accelerates FDA submission, anticipating major advancements in cardiac procedures.
Acrux Limited (ASX:ACR) Raises $1.34 Million from Share Purchase Plan
Acrux Limited (ASX:ACR) raises $1.34 million through its Share Purchase Plan to advance its pharmaceutical development pipeline.
Galileo Mining Ltd (ASX:GAL) Reports Significant PGE Drill Results
Galileo Mining reports significant assay results from its Norseman project, revealing promising PGE mineralization and plans for future exploration.
Black Cat Syndicate Limited (ASX:BC8) Pours First Gold at Paulsens
Black Cat Syndicate pours first gold at Paulsens, marking a significant production milestone for the company.
Genmin Limited (ASX: GEN) Announces Leadership Changes
Genmin Limited appoints Andrew Taplin as CEO and Greg Lilleyman as Board Chair to enhance its project development in Gabon.
CZR Resources Ltd (ASX:CZR) Provides Update on Robe Mesa Sale
CZR Resources Ltd provides an update on the Robe Mesa Iron Ore Project sale, with FIRB approval now pending.
Pengana Private Equity Trust (ASX:PE1) Announces Dividend Distribution
Pengana Private Equity Trust announces a dividend distribution of AUD 0.03176 per unit, payable on January 29, 2025.
Lumos Diagnostics (ASX:LDX) Commences FebriDx CLIA Waiver Study
Lumos Diagnostics announces the launch of the FebriDx CLIA Waiver study, aimed at improving antibiotic use with substantial support from BARDA.
Eildon Capital Group (ASX:EDC) Announces Half Year Dividend
Eildon Capital Group (ASX:EDC) announces a fully franked dividend of 4.0 cents per stapled security for the half year ending December 2024.
EILDON CAPITAL GROUP (ASX:EDC) Announces Dividend Distribution
Eildon Capital Group (ASX:EDC) announces an AUD 0.04 dividend distribution, with payment scheduled for January 22, 2025.